Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Change in Cash (2019 - 2025)

Historic Change in Cash for Sanofi (SNY) over the last 7 years, with Q4 2025 value amounting to -$10.7 billion.

  • Sanofi's Change in Cash fell 68697.52% to -$10.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$40.3 million, marking a year-over-year increase of 9948.0%. This contributed to the annual value of $244.1 million for FY2025, which is 11777.24% up from last year.
  • Per Sanofi's latest filing, its Change in Cash stood at -$10.7 billion for Q4 2025, which was down 68697.52% from $1.7 billion recorded in Q3 2025.
  • In the past 5 years, Sanofi's Change in Cash ranged from a high of $8.3 billion in Q2 2025 and a low of -$10.7 billion during Q4 2025
  • Moreover, its 4-year median value for Change in Cash was $11.8 million (2021), whereas its average is -$863.8 million.
  • Per our database at Business Quant, Sanofi's Change in Cash skyrocketed by 978258.26% in 2021 and then tumbled by 68697.52% in 2025.
  • Sanofi's Change in Cash (Quarter) stood at $11.8 million in 2021, then tumbled by 36862.88% to -$4.3 billion in 2023, then soared by 68.7% to -$1.4 billion in 2024, then plummeted by 686.98% to -$10.7 billion in 2025.
  • Its Change in Cash stands at -$10.7 billion for Q4 2025, versus $1.7 billion for Q3 2025 and $8.3 billion for Q2 2025.